{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "21356620", "DateCompleted": {"Year": "2011", "Month": "10", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1289/ehp.1002681"], "ArticleDate": [{"Year": "2011", "Month": "02", "Day": "28"}], "Journal": {"ISSN": "1552-9924", "JournalIssue": {"Volume": "119", "Issue": "7", "PubDate": {"Year": "2011", "Month": "Jul"}}, "Title": "Environmental health perspectives", "ISOAbbreviation": "Environ Health Perspect"}, "ArticleTitle": "Ambient air pollution and lipoprotein-associated phospholipase A\u2082 in survivors of myocardial infarction.", "Pagination": {"StartPage": "921", "EndPage": "926", "MedlinePgn": "921-6"}, "Abstract": {"AbstractText": ["Increasing evidence suggests a proatherogenic role for lipoprotein-associated phospholipase A\u2082 (Lp-PLA2). A meta-analysis of published cohorts has shown that Lp-PLA2 is an independent predictor of coronary heart disease events and stroke.", "In this study, we investigated whether the association between air pollution and cardiovascular disease might be partly explained by increased Lp-PLA2 mass in response to exposure.", "A prospective longitudinal study of 200 patients who had had a myocardial infarction was performed in Augsburg, Germany. Up to six repeated clinical examinations were scheduled every 4-6 weeks between May 2003 and March 2004. Supplementary to the multicenter AIRGENE protocol, we assessed repeated plasma Lp-PLA2 concentrations. Air pollution data from a fixed monitoring site representing urban background concentrations were collected. We measured hourly means of particle mass [particulate matter (PM) < 10 \u00b5m (PM\u2081\u2080) and PM < 2.5 \u00b5m (PM(2.5)) in aerodynamic diameter] and particle number concentrations (PNCs), as well as the gaseous air pollutants carbon monoxide (CO), sulfur dioxide (SO\u2082), ozone (O\u2083), nitric oxide (NO), and nitrogen dioxide (NO\u2082). Data were analyzed using mixed models with random patient effects.", "Lp-PLA2 showed a positive association with PM\u2081\u2080, PM(2.5), and PNCs, as well as with CO, NO\u2082, NO, and SO\u2082 4-5 days before blood withdrawal (lag 4-5). A positive association with O\u2083 was much more immediate (lag 0). However, inverse associations with some pollutants were evident at shorter time lags.", "These preliminary findings should be replicated in other study populations because they suggest that the accumulation of acute and subacute effects or the chronic exposure to ambient particulate and gaseous air pollution may result in the promotion of atherosclerosis, mediated, at least in part, by increased levels of Lp-PLA2."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Epidemiology II, Helmholtz Zentrum M\u00fcnchen, German Research Center for Environmental Health, Neuherberg, Germany. brueske@helmholtz-muenchen.de"}], "Identifier": [], "LastName": "Br\u00fcske", "ForeName": "Irene", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hampel", "ForeName": "Regina", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Baumg\u00e4rtner", "ForeName": "Zita", "Initials": "Z"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "R\u00fcckerl", "ForeName": "Regina", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Greven", "ForeName": "Sonja", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Koenig", "ForeName": "Wolfgang", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Peters", "ForeName": "Annette", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Schneider", "ForeName": "Alexandra", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Health Perspect", "NlmUniqueID": "0330411", "ISSNLinking": "0091-6765"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "EC 3.1.1.47", "NameOfSubstance": "1-Alkyl-2-acetylglycerophosphocholine Esterase"}], "MeshHeadingList": [{"QualifierName": ["blood"], "DescriptorName": "1-Alkyl-2-acetylglycerophosphocholine Esterase"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["analysis", "toxicity"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Germany"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Longitudinal Studies"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["chemically induced", "epidemiology"], "DescriptorName": "Myocardial Infarction"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": [], "DescriptorName": "Seasons"}, {"QualifierName": [], "DescriptorName": "Surveys and Questionnaires"}], "CoiStatement": "The authors declare they have no actual or potential competing financial interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aalto P, H\u00e4meri K, Paatero P, Kulmala M, Bellander T, Berglind N, et al. Aerosol particle number concentration measurements in five European cities using TSI-3022 condensation particle counter over a three-year period during health effects of air pollution on susceptible subpopulations. J Air Waste Manag Assoc. 2005;55(8):1064\u20131076.", "ArticleIdList": ["16187577"]}, {"Citation": "Akaike H. In: Second International Symposium on Information Theory (Petrov BN, Csaki F, eds) Budapest: Akademiai Kiado; 1973. Information theory and an extension of the maximum likelihood principle. pp. 267\u2013281."}, {"Citation": "Alpert JS, Thygesen K, Antman E, Bassand JP, et al. Myocardial infarction redefined\u2014a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36(3):959\u2013969.", "ArticleIdList": ["10987628"]}, {"Citation": "Anderson JL. Lipoprotein-associated phospholipase A(2): an independent predictor of coronary artery disease events in primary and secondary prevention. Am J Cardiol. 2008;101(12A):23F\u201333F.", "ArticleIdList": ["18549868"]}, {"Citation": "Balsinde J, Balboa MA, Dennis EA. Functional coupling between secretory phospholipase A2 and cyclooxygenase-2 and its regulation by cytosolic group IV phospholipase A2. Proc Natl Acad Sci U.S.A. 1998;95(14):7951\u20137956.", "ArticleIdList": ["PMC20910", "9653121"]}, {"Citation": "Beck-Speier I, Dayal N, Karg E, Maier K, Schumann G, Schulz H, et al. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med. 2005;38(8):1080\u20131092.", "ArticleIdList": ["15780766"]}, {"Citation": "Brook RD, Rajagopalan S, Pope CA, III, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331\u20132378.", "ArticleIdList": ["20458016"]}, {"Citation": "Cyrys J, Pitz M, Heinrich J, Wichmann HE, Peters A. Spatial and temporal variation of particle number concentration in Augsburg, Germany. Sci Total Environ. 2008;401(1\u20133):168\u2013175.", "ArticleIdList": ["PMC2583026", "18511107"]}, {"Citation": "de Hartog JJ. Effects of fine and ultrafine particles on cardiorespiratory symptoms in elderly subjects with coronary heart disease: the ULTRA study. Am J Epidemiol. 2003;157(7):613\u2013623.", "ArticleIdList": ["12672681"]}, {"Citation": "de Hartog JJ, Lanki T, Timonen KL, Hoek G, Janssen NA, Ibald-Mulli A, et al. Associations between PM2.5 and heart rate variability are modified by particle composition and beta-blocker use in patients with coronary heart disease. Environ Health Perspect. 2009;117(1):105\u2013111.", "ArticleIdList": ["PMC2627852", "19165395"]}, {"Citation": "Gorelick PB. Lipoprotein-associated phospholipase A2 and risk of stroke. Am J Cardiol. 2008;101(12A):34F\u201340F.", "ArticleIdList": ["18549870"]}, {"Citation": "Greven S, K\u00fcchenhoff H, Peters A. Additive mixed models with P-splines. 2006.  Available:  http://www.stat.uni-muenchen.de/~greven/files/greven_iwsm06.pdf [accessed 30 May 2011]"}, {"Citation": "Hill AM, Fleming JA, Kris-Etherton PM. The role of diet and nutritional supplements in preventing and treating cardiovascular disease. Curr Opin Cardiol. 2009;24(5):433\u2013441.", "ArticleIdList": ["19638931"]}, {"Citation": "Iribarren C, Gross MD, Darbinian JA, Jacobs DR, Sidney S, Loria CM. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults \u2013 the CARDIA study. Arterioscler Thromb Vasc Biol. 2005;25(1):216\u2013221.", "ArticleIdList": ["15499045"]}, {"Citation": "Katsouyanni K, Schwartz J, Spix C, Touloumi G, Zmirou D, Zanobetti A, et al. Short-term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health. 1996;50(suppl 1):S12\u2013S18.", "ArticleIdList": ["PMC1060882", "8758218"]}, {"Citation": "Khuseyinova N, Greven S, Ruckerl R, Trischler G, Loewel H, Peters A, et al. Variability of serial lipoprotein-associated phospholipase A2 measurements in post-myocardial infarction patients: results from the AIRGENE Study Center Augsburg. Clin Chem. 2008;54(1):124\u2013130.", "ArticleIdList": ["18024527"]}, {"Citation": "Koenig W, Khuseyinova N. Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence. Cardiovasc Drugs Ther. 2009;23(1):85\u201392.", "ArticleIdList": ["18949547"]}, {"Citation": "Koenig W, Twardella D, Brenner H, Rothenbacher D. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol. 2006;26(7):1586\u20131593.", "ArticleIdList": ["16627803"]}, {"Citation": "Koenig W, Vossen CY, Mallat Z, Brenner H, Benessiano J, Rothenbacher D. Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. Eur Heart J. 2009;30(22):2742\u20132748.", "ArticleIdList": ["19666896"]}, {"Citation": "Lerman A, McConnell J. Lipoprotein-associated phospholipase A2: a risk marker or a risk factor? Am J Cardiol. 2008;101(A12):11F\u201322F.", "ArticleIdList": ["18549867"]}, {"Citation": "Lp-PLA (2) Studies Collaboration, Thompson A, Gao P, Orfei L, Watson S, Di Angelantonio E, et al. 2010Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 37597251536\u20131544.", "ArticleIdList": ["PMC2864403", "20435228"]}, {"Citation": "Macphee CH, Moores KE, Boyd HF, Dhanak D, Ife RJ, Leach CA, et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J. 1999;338(Pt 2):479\u2013487.", "ArticleIdList": ["PMC1220076", "10024526"]}, {"Citation": "McConnell JP, Hoefner DM. Lipoprotein-associated phospholipase A2. Clin Lab Med. 2006;26(3):679\u2013697.", "ArticleIdList": ["16938590"]}, {"Citation": "Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103(23):2810\u20132815.", "ArticleIdList": ["11401937"]}, {"Citation": "Peters A, Schneider A, Greven S, Bellander T, Forastiere F, Ibald-Mulli A, et al. Air pollution and inflammatory response in myocardial infarction survivors: gene\u2013environment interactions in a high-risk group. Inhal Toxicol. 2007;19(suppl 1):161\u2013175.", "ArticleIdList": ["17886064"]}, {"Citation": "Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE, et al. Exposure to traffic and the onset of myocardial infarction. N Engl J Med. 2004;351(17):1721\u20131730.", "ArticleIdList": ["15496621"]}, {"Citation": "Puustinen A, H\u00e4meri K, Pekkanen J, Kulmala M, de Hartog J, Meliefste K, et al. Spatial variation of particle number and mass over four European cities. Atmos Environ. 2007;41(31):6622\u20136636."}, {"Citation": "R\u00fcckerl R, Greven S, Ljungman P, Aalto P, Antoniades C, Bellander T, et al. Air Pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect. 2007;115(7):1072\u20131080.", "ArticleIdList": ["PMC1913563", "17637925"]}, {"Citation": "Schwartz J. Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology. 1997;8(4):371\u2013377.", "ArticleIdList": ["9209849"]}, {"Citation": "Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol. 2005;25(5):923\u2013931.", "ArticleIdList": ["15731492"]}]}], "History": [{"Year": "2010", "Month": "7", "Day": "6"}, {"Year": "2011", "Month": "2", "Day": "28"}, {"Year": "2011", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "3", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "10", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21356620", "PMC3223011", "10.1289/ehp.1002681"]}}], "PubmedBookArticle": []}